Walgreens-Boots Alliance struggles with margin compression, competition, and financial risks. Learn why these challenges make ...

Congressional leaders in December struck a deal to rein in PBM practices, but the bill fell apart ... A 2018 study estimated ...

In fact, a recent report found that 52% of employers are considering changing their PBM in the next 1-3 years. While 72% of employers still primarily contract with a Big Three PBM, 12% have ...

Excerpts from recent editorials in the United States and abroad: ___ Jan. 26 The Washington Post on Trump's “energy emergency” Oil and gas production in the United States is hitting record highs, ...

As shown below, CI is fairly diversified, with 40% of earnings coming form healthcare, 30% from specialty pharmacy and care services, and 30% from PBM (pharmacy ... earnings to $1.9 billion ...

The City of Greensboro, North Carolina, which provides public safety, emergency, and health services to over 300,000 residents and spends millions annually on insulin medications, filed a lawsuit ...

The FTC’s investigation into PBM practices began in 2022 ... “In 2024, we helped eligible patients save $1.3 billion and the median out-of-pocket payment for these patients was $5.” ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...

Related: Warren, Hawley propose PBM Act to break up CVS, UnitedHealth A package of healthcare bills including measures that targeted transparency, spread pricing and drug rebates fell off a ...

Debra Patt, MD, PhD, MBA, MPH, emphasizes advocacy for pharmacy benefit manager (PBM) reform, physician reimbursement, and sustainable policy solutions to improve access to community cancer care.

At a news conference, pharmacists held signs reading "PBM reform now" and "patients can't wait." The bill's supporters framed it as part of the solution to addressing both high drug prices and ...

The new approach will protect patients from paying inflated list prices for medications, instead providing them with the lower prices negotiated by the PBM, according to a Jan. 29 news release ...